Martin Duddy
Overview
Explore the profile of Martin Duddy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
1706
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Tintore M, Alexander M, Costello K, Duddy M, Jones D, Law N, et al.
Patient Prefer Adherence
. 2017 Jan;
11:33-45.
PMID: 28053511
Background: Managing multiple sclerosis (MS) treatment presents challenges for both patients and health care professionals. Effective communication between patients with MS and their neurologist is important for improving clinical outcomes...
22.
Kay M, Rogoveanu R, Hodson J, Tallowin S, Hopkins J, Duddy M, et al.
Vasc Endovascular Surg
. 2015 Nov;
49(8):228-35.
PMID: 26584581
Introduction: The aim of this study was to assess the durability of superficial femoral artery (SFA) stents and factors that affect stent patency. Methods: A retrospective assessment of 214 SFA...
23.
24.
Emmanuel Y, Gordon-Smith J, McKillop G, Duddy M, Clift P
J Vasc Interv Radiol
. 2015 Sep;
26(10):1539-43.
PMID: 26408217
The Loeys-Dietz syndrome is a multisystem connective tissue disorder characterized by aortopathy, arterial tortuosity, peripheral aneurysms, and skeletal features. The peripheral arteriopathy is an important cause of morbidity and potential...
25.
Duddy M, Lee M, Pearson O, Nikfekr E, Chaudhuri A, Percival F, et al.
Mult Scler Relat Disord
. 2015 Apr;
3(4):450-6.
PMID: 25877056
Background: The fixed, progressive disability associated with late Multiple Sclerosis (MS) is known to have a major impact on patients and their families, but the impact of relapse earlier in...
26.
Palace J, Duddy M, Bregenzer T, Lawton M, Zhu F, Boggild M, et al.
Lancet Neurol
. 2015 Apr;
14(5):497-505.
PMID: 25841667
Background: In 2002, the UK's National Institute for Clinical Excellence (NICE) concluded that interferon beta and glatiramer acetate would be cost effective as disease-modifying therapies (DMTs) for multiple sclerosis only...
27.
Boulicault D, Duddy M
Neurodegener Dis Manag
. 2015 Feb;
5(1):7-10.
PMID: 25711449
No abstract available.
28.
Palace J, Bregenzer T, Tremlett H, Oger J, Zhu F, Zhu F, et al.
BMJ Open
. 2014 Jan;
4(1):e004073.
PMID: 24441054
Objectives: In 2002, the UK's National Institute for Health and Care Excellence concluded that the multiple sclerosis (MS) disease modifying therapies; interferon-β and glatiramer acetate, were not cost effective over...
29.
Beecham A, Patsopoulos N, Xifara D, Davis M, Kemppinen A, Cotsapas C, et al.
Nat Genet
. 2013 Oct;
45(11):1353-60.
PMID: 24076602
Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis and 24,091 healthy controls for 161,311 autosomal variants and identified 135 potentially associated regions (P < 1.0...
30.
Hollingsworth A, Duddy M, Tiwari A
Vasc Endovascular Surg
. 2013 Aug;
47(8):656-9.
PMID: 23938866
Vein graft stenosis is a well-recognized complication of infrainguinal bypass surgery. Balloon angioplasty is an accepted method for managing vein graft stenosis in selected patients. This intervention is not without...